在一个随机对照的交叉试验中,与根/粉碎蔬菜相比,十字花蔬菜可以改善血糖控制:血管健康的 VEgetableS (VESSEL) 研究

相关实验视频

Updated: May 17, 2025

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography HPLC

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography HPLC

Published on: March 15, 2017

Emma L Connolly¹, Alex H Liu¹, Richard J Woodman²

¹Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.

Diabetes, obesity & metabolism

|May 16, 2025

概括

在患有高血压的成年人中,与根蔬菜相比,十字花蔬菜,如西兰花,改善了血糖控制. 这种饮食干预减少了饭后葡萄糖峰值,这表明对代谢健康有好处.

科学领域:

营养科学营养科学
代谢健康代谢健康
饮食干预饮食干预

背景情况:

较高的十字花蔬菜摄入量与降低2型糖尿病和心血管疾病的风险有关.
有限的因果证据证实了十字类蔬菜对血糖的益处.
这项研究调查了十字花蔬菜对非糖尿病成人高血压的血糖控制的影响.

研究的目的:

为了确定与根/粉末蔬菜相比,十字花蔬菜的消费是否能改善血糖控制.
评估对连续葡萄糖,血糖变异性和食后葡萄糖反应的影响.
为了评估高血压的成年人的临床影响.

主要方法:

一个随机的,受控的,交叉试验,有两个2周的饮食干预措施 (十字花和根/粉末).
提供标准的午餐和晚餐,干预之间有2周的洗期.
连续血糖监测 (CGM) 和快速血糖监测用于每15分钟测量间歇性血糖.

主要成果:

与对照组相比,食用十字花蔬菜显著降低了血糖变化 (CV).
整体食后葡萄糖反应 (PPGR) 和曲线下的面积 (AUC) 在十字花类蔬菜中较低,特别是在晚餐后.
在两个干预措施之间,没有观察到持续平均葡萄糖水平的显著差异.

结论:

与根/粉末蔬菜相比,食用十字花蔬菜明显改善了食后血糖控制.
这些发现的临床意义需要进一步调查,特别是在血糖控制受损的个体中.
这项研究提供了证据,支持十字植物蔬菜在控制血糖水平方面的作用.

关键词:

心血管疾病心血管疾病十字花蔬菜十字花蔬菜糖尿病糖尿病患者糖尿病患者葡萄糖酸盐是一种葡萄糖.血糖控制血糖控制血糖控制吃饭后的葡萄糖反应随机对照试验是随机对照试验.

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

The Scientific Method

The Scientific Method

The scientific method is a detailed, empirical problem-solving process used by biologists and other scientists. This iterative approach involves formulating a question based on observation, developing a testable potential explanation for the observation (called a hypothesis), making and testing predictions based on the hypothesis, and using the findings to create new hypotheses and predictions.
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...